GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mind Medicine Inc (OTCPK:MMCWF) » Definitions » Forward PE Ratio

Mind Medicine (Mind Medicine) Forward PE Ratio : 0.00 (As of May. 24, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Mind Medicine Forward PE Ratio?

Mind Medicine's Forward PE Ratio for today is 0.00.

Mind Medicine's PE Ratio without NRI for today is 0.00.

Mind Medicine's PE Ratio for today is 0.00.


Mind Medicine Forward PE Ratio Historical Data

The historical data trend for Mind Medicine's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mind Medicine Forward PE Ratio Chart

Mind Medicine Annual Data
Trend
Forward PE Ratio

Mind Medicine Quarterly Data
Forward PE Ratio

Competitive Comparison of Mind Medicine's Forward PE Ratio

For the Biotechnology subindustry, Mind Medicine's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mind Medicine's Forward PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mind Medicine's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Mind Medicine's Forward PE Ratio falls into.



Mind Medicine Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Mind Medicine  (OTCPK:MMCWF) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Mind Medicine Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Mind Medicine's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Mind Medicine (Mind Medicine) Business Description

Traded in Other Exchanges
Address
One World Trade Center, Suite 8500, New York, NY, USA, 10007
Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies.